3.62 USD
+0.03 (+0.84%)
3.58 USD
-0.04 (-1.1%)
GCTK gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 184 industry peers in the Health Care Equipment & Supplies industry. GCTK may be in some trouble as it scores bad on both profitability and health. GCTK has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
- GCTK had negative earnings in each of the past 5 years.
- GCTK had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- The profitability ratios for GCTK are negative, so there is not much use analyzing them.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for GCTK so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- Compared to 1 year ago, GCTK has more shares outstanding
- GCTK has more shares outstanding than it did 5 years ago.
- GCTK has a better debt/assets ratio than last year.
2.2 Solvency
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | N/A |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | N/A | ||
| Quick Ratio | N/A |
3. Growth
3.1 Past
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
- GCTK does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
GLUCOTRACK INC / GCTK FAQ
What is the ChartMill fundamental rating of GLUCOTRACK INC (GCTK) stock?
ChartMill assigns a fundamental rating of 0 / 10 to GCTK.
What is the valuation status for GCTK stock?
ChartMill assigns a valuation rating of 0 / 10 to GLUCOTRACK INC (GCTK). This can be considered as Overvalued.
What is the profitability of GCTK stock?
GLUCOTRACK INC (GCTK) has a profitability rating of 0 / 10.